Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H13N3O5S |
| Molecular Weight | 335.335 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)[N+]([O-])=O
InChI
InChIKey=GWBPFRGXNGPPMF-UHFFFAOYSA-N
InChI=1S/C14H13N3O5S/c1-10(18)15-11-4-8-14(9-5-11)23(21,22)16-12-2-6-13(7-3-12)17(19)20/h2-9,16H,1H3,(H,15,18)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Influence of luminal monosaccharides on secretion of glutathione conjugates from rat small intestine in vitro. | 2009-11-03 |
|
| Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2). | 2003-06-27 |
|
| Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro. | 1996-12 |
Sample Use Guides
Poultry: conditions of use. It is used in the drinking water of chickens as follows:
Amount. 374–747 milligrams of sulfanitran with 477–954 milligrams of
aklomide.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12702717
500 uM sulfanitran stimulated the vectorial transport of
saquinavir, a recently described MRP2 substrate, across
polarized MDCKII monolayers demonstrating that it also stimulates
MRP2 in intact cells.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29739
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C76978
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
PRIMARY | |||
|
C009349
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
PRIMARY | |||
|
217299
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
PRIMARY | |||
|
m10334
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
PRIMARY | Merck Index | ||
|
1868
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
PRIMARY | |||
|
QT35T5T35Q
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
PRIMARY | |||
|
100000083294
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
PRIMARY | |||
|
CHEMBL493636
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
PRIMARY | |||
|
DB11463
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
PRIMARY | |||
|
77120
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
PRIMARY | |||
|
122-16-7
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
PRIMARY | |||
|
DTXSID4045898
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
PRIMARY | |||
|
Sulfanitran
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
PRIMARY | |||
|
SUB10719MIG
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
PRIMARY | |||
|
5334
Created by
admin on Wed Apr 02 06:51:52 GMT 2025 , Edited by admin on Wed Apr 02 06:51:52 GMT 2025
|
PRIMARY |
ACTIVE MOIETY